Alvin Wong
Hoofd Techniek/Wetenschap/O&O bij PUMA BIOTECHNOLOGY, INC.
Vermogen: 270 759 $ op 31-05-2024
Profiel
Alvin F.
Wong is currently the Chief Scientific Officer at Puma Biotechnology, Inc. He previously worked as the Senior Director-Clinical Development at Proteolix, Inc. from 2007 to 2013.
Prior to that, he served as a Clinical Professor at UCSF School of Pharmacy from 1976 to 1996.
Dr. Wong holds a graduate degree from The University of California, San Francisco.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0.15% | 22-04-2024 | 70 327 ( 0.15% ) | 270 759 $ | 31-05-2024 |
Actieve functies van Alvin Wong
| Bedrijven | Functie | Begin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2017 |
Eerdere bekende functies van Alvin Wong
| Bedrijven | Functie | Einde |
|---|---|---|
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 01-01-2013 |
| UCSF School of Pharmacy | Corporate Officer/Principal | 01-01-1996 |
Opleiding van Alvin Wong
| The University of California, San Francisco | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
